Tag Archives: Therapy

New hearing therapy is music to the ears

Ringing in the ears is annoying, but in the long run it can ruin one’s quality of life. To cure this, a research and development (R&D) company at Yıldız Technical University’s Teknopark developed software that aims to stop the ringing by exposing the patient to music at a certain frequency Developed with the help of… Read More »

Yale experts treat severe, disfiguring sarcoidosis with novel therapy

An all-Yale team of researchers successfully treated a patient with disfiguring sarcoidosis, a disease that can affect multiple organs, with a drug approved for rheumatoid arthritis. Successful treatment of two other patients with similarly severe disease suggests an effective treatment for an incurable, sometimes life-threatening illness is within reach. The research was published in the… Read More »

Anxiety in COPD Benefits From Cognitive Behavioral Therapy vs Self-Help

December 18, 2018 Share this content: Higher initial costs associated with CBT were offset by savings resulting from fewer hospital admissions and emergency department visits in the subsequent 12 months. Cognitive behavioral therapy (CBT) interventions were statistically and clinically superior to self-help leaflets in the treatment of anxiety in patients with chronic obstructive pulmonary disease… Read More »

Medical News Today: Future of Alzheimer's therapy: What is the best approach?

Millions of people worldwide live with a form of dementia, the most common of which is Alzheimer’s disease. Currently, there is no way to halt its progress, but clinical trials of new drugs are underway. What approach will serve specialists best? A new review of clinical trials advises on the best way forward. According to… Read More »

AstraZeneca digs deeper into cancer therapy with a stake in Innate

AstraZeneca is plowing deeper into cancer immunotherapy through a wide-ranging deal with Innate Pharma, which includes the British group buying a 9.8 percent stake in the French biotech company. Tuesday’s agreement is a coup for Innate — run by former AstraZeneca executive Mondher Mahjoubi — which gains rights to sell AstraZeneca’s newly approved rare blood… Read More »